ArticleDrug design, development and therapy2009

Long-term disease-free survivor of metastatic large-cell neuroendocrine carcinoma of the lung treated with amrubicin and irinotecan.

Shinichiro Ryuge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.